[REGN] YoY Annual Result on 31-Dec-2013 [#FY]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
13-Feb-2014
Financial Year
2013
Quarter
31-Dec-2013 [#FY]
Profit Trend
YoY- -43.44%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Annual Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 4,860,427 4,103,728 2,819,557 2,104,745 1,378,477 445,824 459,074 48.12%
PBT 1,329,815 1,225,097 775,747 713,360 414,421 -222,892 -104,468 -
Tax 434,293 589,041 427,673 288,998 -335,848 -1,132 -2,122 -
NP 895,522 636,056 348,074 424,362 750,269 -221,760 -104,468 -
Tax Rate -32.66% -48.08% -55.13% -40.51% 81.04% - - -
Total Cost 3,964,905 3,467,672 2,471,483 1,680,383 628,208 667,584 563,542 38.38%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin 18.42 15.50 12.34 20.16 54.43 -49.74 -22.76 -
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS 8.55 6.17 3.36 4.23 7.92 -2.45 -1.26 -
EPS Diluted 7.70 5.52 2.98 3.72 6.75 -2.45 -1.26 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.